Go to deals
Consumer & Retail | Healthcare

Periproducts Limited has been acquired by Venture Life Group plc

The private shareholders of Periproducts Limited have sold the company to Venture Life Group plc for US$8 million.

Perirpoducts is an independent, privately owned British company that produces and markets the award-winning UltraDEX Performance Oral Care range. Over the last 20 years, the company has been recognized for its innovative oral care products, incorporating the latest ingredients and technology, and backed by scientific research.

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercializing products for the ageing population. The group’s product range and pipeline currently include food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

Oaklins Cavendish, based in the UK, advised the seller in this transaction.

Parties

Talk to the deal team

Peter Gray

Partner
London, United Kingdom
Oaklins Cavendish

Related deals

St. Claraspital AG has been acquired by University Hospital Basel
Healthcare

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).

Learn more
A share exchange agreement for making NARUMIYA a wholly owned subsidiary of World has been executed
Consumer & Retail

A share exchange agreement for making NARUMIYA a wholly owned subsidiary of World has been executed

World Co., Ltd. and NARUMIYA INTERNATIONAL Co., Ltd. have entered into a definitive share exchange agreement, under which World will acquire all outstanding shares of NARUMIYA and make it a wholly owned subsidiary. The share exchange is scheduled to take effect on 1 October 2025. Under the terms of the agreement, NARUMIYA shareholders will receive 0.58 shares of World stock for each Narumiya share they hold.

Learn more
Roxy Nails has sold a minority stake to Cap Invest and Premius Capital
Private Equity | Consumer & Retail

Roxy Nails has sold a minority stake to Cap Invest and Premius Capital

Roxy Nails has sold a minority stake to Cap Invest and Premius Capital, enabling the brand to accelerate growth, expand internationally and strengthen its capabilities by structuring teams and hiring new talent.

Learn more